Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Doxorubicin / Cyclophosphamide / Paclitaxel / Carboplatin|PROCEDURE: Definitive Surgery|RADIATION: Radiotherapy
Sponsor: Leo W. Jenkins Cancer Center